Aksu

发表

Efﬁcacy and quality of life assessment in the use of subcutaneous immunoglobulin treatment for children with primary immunodeﬁciency disorder

B., G., N., 2021 .

K., 2. P, 3. P, 1968, Biological Psychiatry.